Trial Profile
Prospective, Multi-center, Randomized, Active-control, Non-inferiority Study Comparing Fibrinogen Concentrate With Cryoprecipitate for the Treatment of Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2022
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Afibrinogenaemia
- Focus Therapeutic Use
- Acronyms FIBRES
- 27 Jun 2022 Results of post hoc analysis comparing fibrinogen concentrate (4 g) to cryoprecipitate, published in the British Journal of Anaesthesia
- 14 Sep 2021 Results (n=415) of post-hoc analysis of FIBRES study comparing fibrinogen concentrate with cryoprecipitate in bleeding cardiac surgical patients published in the Canadian Journal of Anesthesia
- 05 Nov 2019 According to Octapharma media release, results from this trial were discussed at American Society of Anesthesiologists Annual Meeting